CrelioHealth

Executive Summary

CrelioHealth is a US-based digital health company offering a cloud-native, AI-powered laboratory information system (LIS) and practice management software designed to streamline end-to-end lab operations. Its platform covers order management, sample tracking, reporting, and patient engagement, catering to diverse lab types including toxicology, molecular, and anatomical pathology. By leveraging AI and cloud-native architecture, CrelioHealth enhances operational efficiency, scalability, and compliance with HIPAA and CLIA standards. The company operates on a SaaS model, making it accessible to labs of varying sizes while reducing deployment complexity. With a focus on modernizing legacy lab workflows, CrelioHealth is well-positioned to capture market share in the growing digital diagnostics space. The diagnostics laboratory software market is expanding rapidly, driven by the need for automation, interoperability, and data-driven insights. CrelioHealth differentiates itself through its AI capabilities and flexible, scalable platform, which can adapt to a wide range of lab specialties. While the company is private and does not disclose financials, its targeted approach to streamlining lab operations and improving patient engagement suggests strong growth potential. As healthcare digitization accelerates, CrelioHealth's ability to meet the demands of both small and large labs positions it favorably against legacy competitors. However, competition from well-funded players and the need for continuous innovation remain key risks.

Upcoming Catalysts (preview)

• Q3 2026Launch of advanced AI-powered reporting and decision support module70% success
• TBDStrategic partnership with a national lab chain or health system60% success
• TBDSeries B funding round to support expansion and product development80% success